The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond
Open accessAbstract
Through early detection, newborn screening (NBS) for cystic fibrosis (CF) offers the opportunity for early intervention and improved outcomes. NBS programs screen for hypertrypsinogenemia and most also identify mutations in the CF transmembrane conductance regulator (CFTR) gene. Individuals identified by NBS are diagnosed with CF if they have an elevated sweat chloride or if they have inherited two disease-causing mutations in the CFTR gene. Mutations in the CFTR gene can cause CF, but not all CFTR mutations are disease-causing. The term CFTR-related metabolic syndrome (CRMS) is proposed to describe infants with hypertrypsinogenemia on NBS who have normal or intermediate sweat chloride values and 2 CFTR mutations, including at least one that is not known to cause CF, and thus do not meet CF Foundation guidelines for the diagnosis of CF. Individuals with one CF-causing mutation, no mutation on the other allele and an intermediate sweat chloride are presumed to be CF carriers. With what is now near-universal CF NBS in the United States, an increasing number of infants with CRMS are being identified. Given our inadequate knowledge of the natural history of CRMS, standards for diagnosis, monitoring and treatment are absent. This document aims to help guide the monitoring and care of individuals with CRMS while our knowledge base on appropriate management evolves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RSV Mediates Pseudomonas aeruginosa Binding to Cystic Fibrosis and Normal Epithelial Cells
van Ewijk, B. E., Wolfs, T. F. W., Aerts, P. C., Van Kessel, K. P. M., Fleer, A., Kimpen, J. L. L., & Van Der Ent, C. K. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180332d1c · Cited by 113
Cited by
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Self-citationDiagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
Farrell, P. M., White, T. B., Ren, C. L., Hempstead, S. E., Accurso, F., Derichs, N., Howenstine, M., McColley, S. A., Rock, M., Rosenfeld, M., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.09.064 · Cited by 953
Self-citationRatjen, F., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 546
Sanders, D. B., & Fink, A. K. (2016) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2016.04.001 · Cited by 109
Coffey, M. J., Whitaker, V., Gentin, N., Junek, R., Shalhoub, C., Nightingale, S., Hilton, J., Wiley, V., Wilcken, B., Gaskin, K. J., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.10.045 · Cited by 73
Metadata
- Authors
- Borowitz, D., Parad, R. B., Sharp, J. K., Sabadosa, K. A., Robinson, K. A., Rock, M. J., Farrell, P. M., Sontag, M. K., Rosenfeld, M., Davis, S. D., Marshall, B. C., & Accurso, F. J.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 155
- Issue
- 6
- Pages
- S106-S116
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2009659008
- Cited by
- 213
- References
- 1
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond. https://app.cochat.ai/papers/10.1016/j.jpeds.2009.09.003
- The paper
- Borowitz, D., Parad, R. B., Sharp, J. K., Sabadosa, K. A., Robinson, K. A., Rock, M. J., Farrell, P. M., Sontag, M. K., Rosenfeld, M., Davis, S. D., Marshall, B. C., & Accurso, F. J. (2009). Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond. The Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2009.09.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.